| Authors: |
Elkins KL; Center for Biologics Evaluation and Research, FDA; 10903 New Hampshire Avenue, Room 5342; Silver Spring, MD 20993, USA. Electronic address: karen.elkins@fda.hhs.gov., Mittereder LR; Center for Biologics Evaluation and Research, FDA; 10903 New Hampshire Avenue, Room 5342; Silver Spring, MD 20993, USA. Electronic address: lara.mittereder@fda.hhs.gov., De Pascalis R; Center for Biologics Evaluation and Research, FDA; 10903 New Hampshire Avenue, Room 5342; Silver Spring, MD 20993, USA. Electronic address: roberto.depascalis@fda.hhs.gov., Singer AW; Singer & Associates Toxpath Consulting Solutions, 388 Eagle Pass Dr., Ponte Vedra, FL 32081, USA. Electronic address: singer@toxpathsolutions.com., Moore J; MRIGlobal, 425 Dr. Martin Luther King Jr. Blvd, Kansas City, MO, 64410, USA; Ceva Animal Health, 8735 Rosehill Rd, Lenexa, KS, 66215, USA. Electronic address: jennafer.moore@ceva.com., Nevins C; MRIGlobal, 425 Dr. Martin Luther King Jr. Blvd, Kansas City, MO, 64410, USA; KCAS Bio, 10830 S. Clay Blair Blvd, Olathe, KS, 66061, USA., Lockard J; MRIGlobal, 425 Dr. Martin Luther King Jr. Blvd, Kansas City, MO, 64410, USA; Appili Therapeutics Inc., 2464 Charlotte St. Room 1316, Kansas City, MO, 64108, USA. Electronic address: jlockard@appilitherapeutics.com., Tuttle R; MRIGlobal, 425 Dr. Martin Luther King Jr. Blvd, Kansas City, MO, 64410, USA. Electronic address: rtuttle@currently.com., Sjostedt A; Department of Clinical Microbiology, Umeå University, SE-90185 Umeå, Sweden. Electronic address: anders.sjostedt@umu.se., Conlan JW; Appili Therapeutics Inc., 2464 Charlotte St. Room 1316, Kansas City, MO, 64108, USA., Gelhaus HC; MRIGlobal, 425 Dr. Martin Luther King Jr. Blvd, Kansas City, MO, 64410, USA; Appili Therapeutics Inc., 2464 Charlotte St. Room 1316, Kansas City, MO, 64108, USA. Electronic address: cgelhaus@appilitherapeutics.com. |
